好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Qualitative Study to Characterize the Patient-reported Experience of Menstrual Migraine
Headache
P8 - Poster Session 8 (11:45 AM-12:45 PM)
15-001

To characterize the signs, symptoms, and impacts of menstrual migraine (MM), and to describe differences in intrapersonal experiences of MM compared to non-MM attacks.

MM affects 20-25% of female migraine patients; however, there is a lack of patient-centered research on the experience of MM.

Semi-structured qualitative interviews were conducted with adults with MM ( ≥4 attacks/month, at least 2/3rd associated with menstruation, and <15 monthly headache days). Signs, symptoms, and impacts of MM were elicited, and participants rated the severity and bothersomeness of these concepts on a 0-10 numeric rating scale (higher scores indicating greater severity/bothersomeness). Participants were also asked to compare the intrapersonal experience of their MM and non-MM attacks.

Participants (n=20) had a mean(SD) age of 39.2(7.8) years and were 100% (20/20) female and 90% (18/20) White. The most common signs and symptoms were head pain (100% [20/20]), nausea, fatigue/tiredness, difficulty concentrating (each; 95% [19/20]), and sensitivity to sound (85% [17/20]). Among symptoms reported by ≥ 50% of participants, head pain and fatigue/tiredness were rated as both the most severe (8.2 and 7.7, respectively) and the most bothersome symptoms (8.6 and 8.5, respectively). The most common impacts of MM were difficulty performing in work/school (70% [14/20]), inability to function (50% [10/20]), feeling frustrated (45% [9/20]), and difficulty performing physical activities (40% [8/20]). Compared to their non-MM attacks, participants described their MM attacks as longer (73% [8/11]) and more severe (79% [11/14]), with more frequent (67% [6/9]) and more predictable symptoms (86% [6/7]).

This study identified the signs, symptoms, and impacts that characterize the MM experience. Notably, these concepts were consistent with the migraine experience; however, participants reported that their MM attacks were longer and more severe than their non-MM attacks. Understanding of the MM experience will create potential opportunities for targeted treatments and better outcomes for patients.

Authors/Disclosures
Jessica Ailani, MD, FAAN (Medstar Georgetown Neurology)
PRESENTER
Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Colleen V. Castro Ms. Castro has received personal compensation for serving as an employee of AbbVie. An immediate family member of Ms. Castro has received personal compensation for serving as an employee of ClickHouse. An immediate family member of Ms. Castro has received personal compensation for serving as an employee of ElasticSearch. Ms. Castro has stock in AbbVie. An immediate family member of Ms. Castro has stock in ElasticSearch.
Elizabeth Hribal The institution of Miss Hribal has received research support from AbbVie.
Chris Evans, PhD The institution of Dr. Evans has received research support from AbbVie.
Gina Ahmadyar (AbbVie) Ms. Ahmadyar has received personal compensation for serving as an employee of AbbVie.
Sean Delaney The institution of Mr. Delaney has received research support from AbbVie.
Marc Bacharach The institution of Mr. Bacharach has received research support from AbbVie.
Amit Bodhani, Other (Abbvie) Mr. Bodhani has received personal compensation for serving as an employee of AbbVie. Mr. Bodhani has stock in AbbVie.
Krutika Jariwala-Parikh, PhD (AbbVie) Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.